The CLCN1 gene makes a channel that helps muscle cells reset after they contract, so muscles can relax normally. In medicine, this gene is important because it helps regulate the tiny electrical signals that tell muscles when to tense and when to let go. If it does not work well, muscles may stay tight for longer than usual, causing stiffness, trouble releasing a grip, or difficulty starting to move after rest. Variants in the CLCN1 gene are linked to myotonia congenita, a condition that affects how easily muscles relax.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they occur, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
CLCN1Gene function
What if the gene works
The CLCN1 gene makes a chloride channel in skeletal muscle. This channel helps muscle cells reset after contraction, so muscles can relax normally and respond smoothly to repeated movement.
Risk
What if the gene does not work
Variants in the CLCN1 gene can cause myotonia congenita, with muscle stiffness and delayed relaxation after movement. Milder to more severe variants may affect how early symptoms appear and how noticeable the stiffness is.
Treatment
What does that mean for your treatment
For people with pathogenic variants in the CLCN1 gene, treatment is usually symptom based rather than tailored to the exact variant. Mexiletine is a well established first line medicine that can reduce myotonia and improve day to day movement. During anesthesia, drugs that may trigger marked muscle stiffness, especially succinylcholine, are generally avoided.
Conditions associated with CLCN1
Gene function
What if the gene works
Each time you move, your muscle cells need electrical signals that switch on and off in a controlled way. The CLCN1 gene helps make a channel in skeletal muscle that lets chloride ions move across the cell membrane. This is a key part of what the CLCN1 gene does in muscle, helping muscles contract and then settle back to rest.
The CLCN1 gene helps skeletal muscle cells keep a stable electrical charge at rest. Its channel lets chloride ions move through the muscle cell membrane, which supports smooth, controlled signaling.
After a muscle cell is activated, this channel helps calm the electrical signal back down. That makes it easier for the muscle fiber to stop firing once the movement signal has passed.
By limiting extra electrical activity, the CLCN1 gene supports normal muscle relaxation after contraction. This steady reset helps everyday movements, like releasing your grip or relaxing your legs after a step, feel more controlled.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help account for normal human differences, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CLCN1 gene often change the CLCN1 protein’s shape, stability, or opening behavior, which can reduce chloride channel activity in muscle cell membranes. Some CLCN1 gene variants have a mild effect, while more severe variants, or two damaging variants together, may leave very little activity. That functional drop can influence how early myotonia congenita begins and how noticeable muscle stiffness becomes.
How variants are linked to conditions
Pathogenic variants in the CLCN1 gene cause myotonia congenita, a condition marked by muscle stiffness that is often most noticeable after rest. This includes Thomsen disease, which usually follows a dominant inheritance pattern, and Becker myotonia congenita, which is usually recessive and often more pronounced. Different CLCN1 gene variants can lead to different symptom patterns and levels of severity.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead represent natural human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CLCN1, the chance of having myotonia congenita is mainly set by the gene change itself, not by lifestyle. Cold temperatures, stress, and rest after exercise can make muscle stiffness more noticeable, but there is not enough evidence to say lifestyle changes lower the underlying genetic risk.
Inheritance of CLCN1 variants
For the CLCN1 gene, the inheritance pattern can differ depending on the specific condition and variant involved. CLCN1-related myotonia congenita may be inherited in an autosomal dominant pattern or an autosomal recessive pattern. In the dominant form, a parent carrying the variant can pass it to a child with a 1 in 2, or 50%, chance in each pregnancy. In the recessive form, a child usually inherits one CLCN1 gene variant from each parent, and when both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance of the child being affected.
What does my CLCN1 result mean for my family?
Changes in the CLCN1 gene can run in families, but what this means for relatives depends on the specific form of the condition. Some CLCN1-related myotonia is passed down in a dominant way, so a parent, child, brother, or sister may also have the variant. Other CLCN1-related cases are recessive, which means relatives may be healthy carriers without symptoms. Because this gene is linked to more than one inheritance pattern, family implications are best understood in the context of the exact result.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the CLCN1 gene, genetic testing for the CLCN1 gene uses a blood or saliva sample to read the gene’s DNA code. A lab checks for changes linked with myotonia congenita and reports whether a variant was found, which can help confirm a diagnosis or clarify whether the result is uncertain.
When should I consider getting a genetic test?
Consider testing for changes in the CLCN1 gene if there is ongoing muscle stiffness, trouble relaxing your grip after squeezing something, or a family history of inherited muscle stiffness, often called myotonia congenita. Testing can help confirm whether CLCN1 is the cause and clarify the chance it runs in a family.
A genetic result is only one part of your health story
A genetic finding can be informative, but how much it explains varies depending on the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This common part of human biology can influence how well a medicine works and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CLCN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so questions about medicines, side effects, or symptoms are best discussed with your doctor. Some small studies in CLCN1-related muscle stiffness have looked at whether certain gene changes affect response to medicines used for myotonia, but this is not yet part of routine prescribing.
History
Throughout history, people have described episodes of muscle stiffness that ran in families, long before the cause was known. In 1876, the Danish physician Julius Thomsen gave one of the first detailed accounts after describing his own family’s condition, now known as Thomsen myotonia congenita. In the 1970s, Peter Emil Becker helped distinguish a more common recessive form, which became known as Becker myotonia congenita. Building on this early work, scientists linked these inherited forms of myotonia to the CLCN1 gene in the early 1990s. That discovery helped connect older bedside observations with modern genetic testing. Over time, descriptions became more precise, and the history of the CLCN1 gene became part of the broader story of inherited muscle conditions.